✦ LIBER ✦

Retinoid and interferon-α: a new promising combination chemotherapy for cervical cancer

✍ Scribed by Ming-Chu Hsu

Book ID: 118893349
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 86 KB
Volume: 49
Category: Article
ISSN: 0020-7292
DOI: 10.1016/0020-7292(95)94116-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retinoids and interferon: a new promisin

Retinoids and interferon: a new promising combination?

✍ W. Bollag 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB

P71 Epirubicin (EPI) and vinorelbine (VN

P71 Epirubicin (EPI) and vinorelbine (VNR): A new promising combination for primary systemic chemotherapy for breast cancer

✍ C. Nisticò; A. de Matteis; R. Valenza; D. Quattrocchio; C. Garufi; A. Maiorino; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Promising results achieved with a combin

Promising results achieved with a combination of chemotherapy and two retinoids in patients with advanced non-small-cell lung cancer

✍ Nandan, Raghu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Preoperative combination chemotherapy fo

Preoperative combination chemotherapy for advanced stage head and neck cancer: Promising early results

✍ Merrill S. Kies; Bernard C. Pecaro; Leo I. Gordon; Walter W. Hauck; Michael J. K 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 667 KB

Systemic Combined Chemotherapy with Low

Systemic Combined Chemotherapy with Low Dose of 5-Fluorouracil, Cisplatin, and Interferon-α for Advanced Hepatocellular Carcinoma: A Pilot Study

✍ Yasuji Komorizono; Kazunori Kohara; Makoto Oketani; Masahiko Maeda; Toshihiko Sh 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 30 KB

Pilot study of combination chemotherapy

Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-α for advanced hepatocellular carcinoma with extrahepatic metastasis

✍ Masato Nakamura; Hiroaki Nagano; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Tak 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

## Abstract ## BACKGROUND. To the authors' knowledge, there is no effective therapy for extrahepatic metastasis of hepatocellular carcinoma (HCC). In a pilot study, the results of combination therapy of S‐1, a novel oral dehydropyrimidine dehydrogenase (DPD) inhibitor, and interferon‐alpha (IFN‐α)